Pulmonary fibrosis has a life changing impact on all aspects of life for patients’ and their families. By listening to their lived experiences, we know that investment in research is desperately needed to provide hope for a better future.
Pulmonary Fibrosis Research Priorities
APF supports and funds research with the potential to aid the discovery of an effective treatment, and/or accelerate change which will enable our community to live well for longer.
By listening to patients, carers, health care professionals and scientists within our community, we have identified four broad areas for investment in research:
- Early and accurate diagnosis
- The development of effective treatments or a cure
- Enabling patients, carers and families to live well for longer
- Understanding of the biological basis of pulmonary fibrosis
We understand how important it is to accurately identify the priority areas of unmet need within our community. As part of our on-going review of research priorities, APF partnered with Imperial College London and the James Lind Alliance to carry out a Priority Setting Partnership for pulmonary fibrosis. The partnership brought together patients, carers and clinicians to jointly agree the Top 10 research priorities for progressive pulmonary fibrosis. We welcome applications for funding that address one or more of these priorities.